Choline transporter-like protein 5 (CTL5), encoded by the SLC44A5 gene, is a member of the solute carrier family 44. As a transporter protein, CTL5 is predicted to play a critical role in transmembrane transport processes, which are fundamental for cellular function and homeostasis. The protein is believed to be primarily localized in the plasma membrane and is involved in the intricate exchange of molecules across the cell's lipid bilayer. CTL5's expression is not limited to a single tissue type; instead, it exhibits a broad expression pattern, with notable presence in skin and testis, as well as various other tissues. This widespread expression suggests that CTL5 could be a key player in several physiological processes, including the maintenance of cellular integrity and the facilitation of nutrient and ion transport.
The expression of CTL5, like many genes, is subject to intricate regulation by a network of signaling pathways and molecular interactions. Certain chemical compounds have the potential to act as activators, upregulating the expression of CTL5. For instance, retinoic acid, a metabolite of vitamin A, is well-documented for its ability to induce gene expression related to cell differentiation and may stimulate CTL5 transcription in a similar context. Forskolin, which increases intracellular cAMP, could also serve as an activator, promoting CTL5 expression through cAMP-responsive pathways. Other compounds, such as 5-Azacytidine and Trichostatin A, may indirectly stimulate CTL5 expression by modifying the epigenetic landscape; they facilitate a more transcriptionally active chromatin state, thereby enhancing the transcription of various genes, potentially including CTL5. Even though the exact mechanisms remain to be elucidated, these chemicals represent a starting point for understanding the complex regulatory environment that controls CTL5 expression. It is through the exploration of these activators that we can begin to piece together the broader picture of CTL5's role in cellular function.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid may upregulate CTL5 expression through its role in cell differentiation and gene transcription specific to developmental pathways where CTL5 is implicated. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
By elevating intracellular cAMP, forskolin could stimulate the transcriptional activity of genes like CTL5 via activation of cAMP-dependent pathways. | ||||||
3,5-Diiodo-L-thyronine | 1041-01-6 | sc-216601 sc-216601A sc-216601B sc-216601C sc-216601D | 1 g 5 g 10 g 25 g 100 g | $265.00 $551.00 $920.00 $1380.00 $2621.00 | 2 | |
This thyroid hormone analog could enhance CTL5 expression by engaging thyroid hormone response elements in CTL5 gene promoters. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound could induce the expression of CTL5 by hypomethylation of DNA, thereby permitting the transcription machinery greater access to the CTL5 gene. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
As an epigenetic modifier, trichostatin A has the potential to increase CTL5 expression by altering histone acetylation and facilitating a more open chromatin state. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $60.00 $270.00 $350.00 | 48 | |
AICAR might stimulate CTL5 transcription through activation of AMPK, which can lead to an upsurge in the expression of genes involved in cellular energy homeostasis. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate could enhance CTL5 gene expression by inhibiting histone deacetylase, resulting in hyperacetylation of histones and increased gene transcription. | ||||||
Losartan Potassium | 124750-99-8 | sc-204796 sc-204796B sc-204796C sc-204796A | 1 g 25 g 100 g 5 g | $53.00 $377.00 $1030.00 $124.00 | 10 | |
Losartan Potassium could theoretically stimulate CTL5 expression as part of cytoprotective mechanisms, especially in tissues with high oxygen turnover. | ||||||
L-3,3′,5-Triiodothyronine, free acid | 6893-02-3 | sc-204035 sc-204035A sc-204035B | 10 mg 100 mg 250 mg | $40.00 $75.00 $150.00 | ||
Triiodothyronine may upregulate CTL5 expression through thyroid hormone receptors, which can initiate transcriptional responses in energy metabolism-related genes. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone may stimulate CTL5 expression via the glucocorticoid response element, which can enhance transcription of genes involved in metabolic regulation. |